Therefore, we conducted a systematic review with network meta-analysis to compare the efficacy and safety of all kinds of CGRP monoclonal antibodies and performed a comprehensive ranking of various medications to determine which medication can efficiently and safely reduce migraine headache days per month. Here, CALCA is linked to migraine disorder.